Created by potrace 1.16, written by Peter Selinger 2001-2019beatandraise.com
Latest Financials

Filings:

CategoryDateSearch FilingsInstitutional HoldersbetaEarnings TranscriptsbetaGlobal Search

SEC Edgar

Intellia Therapeutics, Inc.

SIC 2835 · In Vitro & In Vivo Diagnostic Substances
NotesSupport
aboutterms
$NTLA

Intellia Therapeutics, Inc.

CIK:0001652130|SEC Filings

MATERIAL CONTRACTS

EX-10.1
ntla-ex101_6.htm
2021-06-17T00:00:00Z
EX-10.2
ntla-ex102_148.htm
2021-05-06T00:00:00Z
EX-10.1
ntla-ex101_147.htm
2021-05-06T00:00:00Z
EX-10.3
ntla-ex103_149.htm
2021-05-06T00:00:00Z
EX-10.21
ntla-ex1021_10.htm
2021-02-26T00:00:00Z
EX-10.3
ntla-ex103_272.htm
2020-08-06T00:00:00Z
EX-10.2
ntla-ex102_227.htm
2020-05-07T00:00:00Z
EX-10.1
ntla-ex101_228.htm
2020-05-07T00:00:00Z
EX-10.21
ntla-ex1021_527.htm
2020-02-27T00:00:00Z
EX-10.1
ntla-ex101_195.htm
2019-05-02T00:00:00Z
EX-10.19
ntla-ex1019_488.htm
2019-02-27T00:00:00Z
EX-10.1
ntla-ex101_327.htm
2018-10-31T00:00:00Z
EX-10.3
ntla-ex10_3.htm
2026-08-06T00:00:00Z
EX-10.1
ntla-ex10_1.htm
2026-05-11T00:00:00Z
EX-10.2
ntla-ex10_2.htm
2026-05-11T00:00:00Z
EX-10.25
ntla-ex10_25.htm
2026-02-26T00:00:00Z
EX-10.29
ntla-ex10_29.htm
2026-02-26T00:00:00Z
EX-10.1
d822257dex101.htm
2024-06-26T00:00:00Z
EX-10.2
d822257dex102.htm
2024-06-26T00:00:00Z
EX-10.2
d830395dex102.htm
2020-06-01T00:00:00Z